Roche Molecular Systems, Inc. · Class II · Cleared Jul 6, 2022
| K-number | K213822 |
| Device name | cobas Influenza A/B & RSV nucleic acid test for use on the cobas Liat System |
| Applicant | Roche Molecular Systems, Inc. |
| Product code | OCC |
| Device class | Class II |
| Decision date | Jul 6, 2022 |
| Decision | Substantially Equivalent |
| Regulation | 866.3980 |
AI extraction for this record is queued and will appear within 24 hours. View full FDA record →
View the full FDA submission: accessdata.fda.gov